Company Profile

DiNonA Inc. is a Korea-based company principally engaged in the manufacturing and sale of medical devices. The Company operates its business through two segments. The Medical Devices Business segment manufactures and sells laser medical devices and medical device accessories. The Biopharmaceutical Business segment manufactures and sells diagnostic reagents and research reagents such as pregnancy test kits, antibody for raw materials, and antibody for leukemia treatment.

Employees

Sector

Pharmaceuticals

More about the company

03/11/21	An unknown buyer agreed to acquire approximately 16.5% stake in DiNonA Inc. from Kumho HT, Inc for KRW 19.9 billion.	CI
27/10/21	Kumho HT, Inc. completed the acquisition of remaining 81% stake in DiNonA Inc..	CI
20/10/20	Samsung Biologics Inks Development Partnership with Dinona for Potential COVID-19 Treatment	CI
30/09/20	DiNonA Inc. completed the acquisition of 9.25% stake in Hwail Pharmaceutical Co.,Ltd. from Park, Pil Joon.	CI
29/09/20	Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 20.02 billion in funding from DiNonA Inc.	CI
17/09/20	DiNonA Inc. agree to acquire 9.25% stake in Hwail Pharmaceutical Co.,Ltd. from Park, Pil Joon for KRW 30.8 billion	CI
27/08/20	Kumho HT, Inc. agreed to acquire remaining 81% stake in DiNonA Inc. for approximately KRW 170 billion.	CI
31/07/20	DiNonA Inc. announced that it has received KRW 19.999996625 billion in funding	CI
30/07/20	Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 20.02 billion in funding from DiNonA Inc.	CI
08/07/20	DiNonA Inc. announced that it expects to receive KRW 39.999995596 billion in funding from Korea Fixed-Income Investment Advisory, Midasdong-a Investment Co.,Ltd., S-MAC CO., Ltd., Kumho HT, Inc.	CI
01/07/20	DiNonA Inc. announced that it expects to receive KRW 19.999996625 billion in funding	CI
18/12/19	Lumimicro Co., Ltd cancelled the acquisition of DiNonA Inc..	CI
27/09/19	Lumimicro Co., Ltd agreed to acquire DiNonA Inc. for approximately KRW 130 billion.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DINONA INC.	-0.39%	-2.07%	-	-	91.27M
ELI LILLY AND COMPANY	-0.40%	+5.83%	+54.71%	+111.83%	1,120B
JOHNSON & JOHNSON	-0.48%	-3.56%	+31.29%	+66.97%	616B
ABBVIE INC.	-0.32%	+1.19%	+22.58%	+95.48%	504B
ROCHE HOLDING AG	+0.24%	+5.58%	+35.22%	+59.40%	367B
MERCK & CO., INC.	-1.12%	-0.64%	+67.42%	+43.90%	360B
NOVARTIS AG	-0.40%	+3.53%	+19.26%	+46.55%	288B
ASTRAZENECA PLC	-0.37%	+3.11%	-1.31%	+18.23%	258B
AMGEN INC.	-0.89%	+2.57%	+41.20%	+52.64%	234B
GILEAD SCIENCES, INC.	-0.99%	+2.87%	+25.70%	+97.28%	194B
Average	-0.53%	+3.31%	+32.90%	+65.81%	437.88B
Weighted average by Cap.	-0.49%	+3.52%	+37.81%	+76.52%

DiNonA Inc. Stock

Stocks

A086080

KR7086080009

Pharmaceuticals

Latest news: DiNonA Inc.

Quotes and Performance

Diagnostic & Testing Substances Manufacturers

Company Profile